ROIV - Roivant Sciences Ltd.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$36.17
DETAILS
HIGH:
$42.00
LOW:
$30.00
MEDIAN:
$37.00
CONSENSUS:
$36.17
UPSIDE:
20.73%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Halvorsen | 6,652,448 | $184.3M | 0.5% | +209,257 | INCREASED |
| Greenblatt | 1,416,091 | $39.2M | 0.1% | +490,898 | INCREASED |
| Cooperman | 1,392,748 | $38.6M | 0.0% | +997,344 | INCREASED |
| Wood | 47,400 | $1.3M | 0.0% | +15,400 | INCREASED |
| Soros | 0 | $0 | -- | -9,492 | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-20 | Venker Eric | officer: President & Immunovant CEO | F-InKind | 34,483 | $32.41 | $1.1M |
| 2026-05-22 | Venker Eric | officer: President & Immunovant CEO | SELL | 200,000 | $30.27 | $6.1M |
| 2026-05-20 | Pulik Richard | officer: CFO | F-InKind | 18,962 | $32.41 | $615K |
| 2026-05-22 | Venker Eric | officer: President & Immunovant CEO | M-Exempt | 200,000 | $3.85 | $770K |
| 2026-04-20 | Venker Eric | officer: President & Immunovant CEO | SELL | 200,000 | $29.59 | $5.9M |
| 2026-04-20 | Pulik Richard | officer: CFO | A-Award | 60,644 | -- | -- |
| 2026-04-20 | Pulik Richard | officer: CFO | A-Award | 84,026 | $29.08 | $2.4M |
| 2026-04-20 | Venker Eric | officer: President & Immunovant CEO | M-Exempt | 200,000 | $3.85 | $770K |
| 2026-04-20 | Humes Jennifer | officer: Chief Accounting Officer | A-Award | 29,173 | -- | -- |
| 2026-04-20 | Humes Jennifer | officer: Chief Accounting Officer | A-Award | 27,157 | $29.08 | $790K |
| 2026-04-17 | Oren Ilan | director | A-Award | 896 | -- | -- |
| 2026-04-17 | Oren Ilan | director | F-InKind | 95 | $29.83 | $3K |
| 2026-04-17 | Epperly Melissa B, | director | A-Award | 670 | -- | -- |
| 2026-04-17 | MOMTAZEE JAMES C | director | A-Award | 469 | -- | -- |
| 2026-04-17 | MOMTAZEE JAMES C | director | F-InKind | 94 | $29.83 | $3K |
| 2026-04-16 | Gline Matthew | director, officer: CEO | SELL | 289,774 | $29.16 | $8.4M |
| 2026-04-08 | Humes Jennifer | officer: Chief Accounting Officer | SELL | 13,538 | $28.37 | $384K |
| 2026-03-31 | Torti Frank | officer: President and Vant Chair | F-InKind | 160,035 | $27.70 | $4.4M |
| 2026-03-30 | Sukhatme Mayukh | director, officer: President & CIO | M-Exempt | 58,391 | $12.68 | $740K |
| 2026-03-30 | Sukhatme Mayukh | director, officer: President & CIO | F-InKind | 29,809 | $26.41 | $787K |
| 2026-03-31 | Sukhatme Mayukh | director, officer: President & CIO | F-InKind | 187,512 | $27.70 | $5.2M |
| 2026-03-30 | Sukhatme Mayukh | director, officer: President & CIO | M-Exempt | 1,306,889 | -- | -- |
| 2026-03-30 | Gline Matthew | director, officer: CEO | M-Exempt | 97,319 | $12.68 | $1.2M |
| 2026-03-30 | Gline Matthew | director, officer: CEO | F-InKind | 53,826 | $26.41 | $1.4M |
| 2026-03-31 | Gline Matthew | director, officer: CEO | F-InKind | 304,684 | $27.70 | $8.4M |